Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory Vyvgart: New Drug to Treat Myasthenia Gravis December 19, 2021September 8, 2022 Efgartigimod developed by Argenx is a strong competitor to Soliris.
